Cargando…

Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system

cAMP responsive element binding protein 3-like 3 (CREB3L3), a transcription factor expressed in the liver and small intestine, governs fasting-response energy homeostasis. Tissue-specific CREB3L3 knockout mice have not been generated till date. To our knowledge, this is the first study using the one...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Yoshimi, Oikawa, Fusaka, Mizuno, Seiya, Ohno, Hiroshi, Yagishita, Yuka, Satoh, Aoi, Osaki, Yoshinori, Takei, Kenta, Kikuchi, Takuya, Han, Song-iee, Matsuzaka, Takashi, Iwasaki, Hitoshi, Kobayashi, Kazuto, Yatoh, Shigeru, Yahagi, Naoya, Isaka, Masaaki, Suzuki, Hiroaki, Sone, Hirohito, Takahashi, Satoru, Yamada, Nobuhiro, Shimano, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904192/
https://www.ncbi.nlm.nih.gov/pubmed/27291420
http://dx.doi.org/10.1038/srep27857
_version_ 1782437108097482752
author Nakagawa, Yoshimi
Oikawa, Fusaka
Mizuno, Seiya
Ohno, Hiroshi
Yagishita, Yuka
Satoh, Aoi
Osaki, Yoshinori
Takei, Kenta
Kikuchi, Takuya
Han, Song-iee
Matsuzaka, Takashi
Iwasaki, Hitoshi
Kobayashi, Kazuto
Yatoh, Shigeru
Yahagi, Naoya
Isaka, Masaaki
Suzuki, Hiroaki
Sone, Hirohito
Takahashi, Satoru
Yamada, Nobuhiro
Shimano, Hitoshi
author_facet Nakagawa, Yoshimi
Oikawa, Fusaka
Mizuno, Seiya
Ohno, Hiroshi
Yagishita, Yuka
Satoh, Aoi
Osaki, Yoshinori
Takei, Kenta
Kikuchi, Takuya
Han, Song-iee
Matsuzaka, Takashi
Iwasaki, Hitoshi
Kobayashi, Kazuto
Yatoh, Shigeru
Yahagi, Naoya
Isaka, Masaaki
Suzuki, Hiroaki
Sone, Hirohito
Takahashi, Satoru
Yamada, Nobuhiro
Shimano, Hitoshi
author_sort Nakagawa, Yoshimi
collection PubMed
description cAMP responsive element binding protein 3-like 3 (CREB3L3), a transcription factor expressed in the liver and small intestine, governs fasting-response energy homeostasis. Tissue-specific CREB3L3 knockout mice have not been generated till date. To our knowledge, this is the first study using the one-step CRISPR/Cas9 system to generate CREB3L3 floxed mice and subsequently obtain liver- and small intestine-specific Creb3l3 knockout (LKO and IKO, respectively) mice. While LKO mice as well as global KO mice developed hypertriglyceridemia, LKO mice exhibited hypercholesterolemia in contrast to hypocholesterolemia in global KO mice. LKO mice demonstrated up-regulation of hepatic Srebf2 and its corresponding target genes. No phenotypic differences were observed between IKO and floxed mice. Severe liver injury was observed in LKO mice fed a methionine-choline deficient diet, a model for non-alcoholic steatohepatitis. These results provide new evidence regarding the hepatic CREB3L3 role in plasma triglyceride metabolism and hepatic and intestinal CREB3L3 contributions to cholesterol metabolism.
format Online
Article
Text
id pubmed-4904192
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49041922016-06-14 Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system Nakagawa, Yoshimi Oikawa, Fusaka Mizuno, Seiya Ohno, Hiroshi Yagishita, Yuka Satoh, Aoi Osaki, Yoshinori Takei, Kenta Kikuchi, Takuya Han, Song-iee Matsuzaka, Takashi Iwasaki, Hitoshi Kobayashi, Kazuto Yatoh, Shigeru Yahagi, Naoya Isaka, Masaaki Suzuki, Hiroaki Sone, Hirohito Takahashi, Satoru Yamada, Nobuhiro Shimano, Hitoshi Sci Rep Article cAMP responsive element binding protein 3-like 3 (CREB3L3), a transcription factor expressed in the liver and small intestine, governs fasting-response energy homeostasis. Tissue-specific CREB3L3 knockout mice have not been generated till date. To our knowledge, this is the first study using the one-step CRISPR/Cas9 system to generate CREB3L3 floxed mice and subsequently obtain liver- and small intestine-specific Creb3l3 knockout (LKO and IKO, respectively) mice. While LKO mice as well as global KO mice developed hypertriglyceridemia, LKO mice exhibited hypercholesterolemia in contrast to hypocholesterolemia in global KO mice. LKO mice demonstrated up-regulation of hepatic Srebf2 and its corresponding target genes. No phenotypic differences were observed between IKO and floxed mice. Severe liver injury was observed in LKO mice fed a methionine-choline deficient diet, a model for non-alcoholic steatohepatitis. These results provide new evidence regarding the hepatic CREB3L3 role in plasma triglyceride metabolism and hepatic and intestinal CREB3L3 contributions to cholesterol metabolism. Nature Publishing Group 2016-06-13 /pmc/articles/PMC4904192/ /pubmed/27291420 http://dx.doi.org/10.1038/srep27857 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Nakagawa, Yoshimi
Oikawa, Fusaka
Mizuno, Seiya
Ohno, Hiroshi
Yagishita, Yuka
Satoh, Aoi
Osaki, Yoshinori
Takei, Kenta
Kikuchi, Takuya
Han, Song-iee
Matsuzaka, Takashi
Iwasaki, Hitoshi
Kobayashi, Kazuto
Yatoh, Shigeru
Yahagi, Naoya
Isaka, Masaaki
Suzuki, Hiroaki
Sone, Hirohito
Takahashi, Satoru
Yamada, Nobuhiro
Shimano, Hitoshi
Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system
title Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system
title_full Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system
title_fullStr Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system
title_full_unstemmed Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system
title_short Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system
title_sort hyperlipidemia and hepatitis in liver-specific creb3l3 knockout mice generated using a one-step crispr/cas9 system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904192/
https://www.ncbi.nlm.nih.gov/pubmed/27291420
http://dx.doi.org/10.1038/srep27857
work_keys_str_mv AT nakagawayoshimi hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT oikawafusaka hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT mizunoseiya hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT ohnohiroshi hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT yagishitayuka hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT satohaoi hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT osakiyoshinori hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT takeikenta hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT kikuchitakuya hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT hansongiee hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT matsuzakatakashi hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT iwasakihitoshi hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT kobayashikazuto hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT yatohshigeru hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT yahaginaoya hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT isakamasaaki hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT suzukihiroaki hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT sonehirohito hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT takahashisatoru hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT yamadanobuhiro hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system
AT shimanohitoshi hyperlipidemiaandhepatitisinliverspecificcreb3l3knockoutmicegeneratedusingaonestepcrisprcas9system